Seeking Alpha

Sanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and...

Sanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and Regeneron Pharmaceuticals (REGN +1%) for the treatment of advanced colon cancer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|